Research programme: stroke therapies - Phylogica

Drug Profile

Research programme: stroke therapies - Phylogica

Alternative Names: PYC-35T; PYC-36S

Latest Information Update: 20 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Phylogica
  • Class Peptide fragments
  • Mechanism of Action Apoptosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Stroke

Most Recent Events

  • 18 Aug 2005 The programme is available for licensing (http://www.phylogica.com)
  • 19 Jul 2004 Early research in Stroke in Australia (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top